Søgeresultater - Andrea Péter
- Showing 1 - 9 results of 9
-
1
-
2
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study af LaForce, Craig, Feldman, Gregory, Spangenthal, Selwyn, Eckert, Joerg H, Henley, Michelle, Patalano, Francesco, D’Andrea, Peter
Udgivet 2016Text -
3
Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study af Kerwin, Edward, Siler, Thomas M., Korenblat, Phillip, White, Alexander, Eckert, Joerg H., Henley, Michelle, Patalano, Francesco, D’Andrea, Peter
Udgivet 2016Text -
4
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study af Wang, Chen, Sun, Tieying, Huang, Yijiang, Humphries, Michael, Bai, Lingyan, Li, Lilly, Wang, Qian, Kho, Pearl, Firth, Roz, D’Andrea, Peter
Udgivet 2015Text -
5
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combinat... af Brittain, Dominic, D’Andrea, Peter, Gruen, Emilie, Hosoe, Motoi, Jain, Devendra, Jauernig, Juergen, Pethe, Abhijit, Scosyrev, Emil, Tanase, Ana-Maria, Tillmann, Hanns-Christian
Udgivet 2022Text -
6
Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data af D’Urzo, Anthony D, Kerwin, Edward M, Chapman, Kenneth R, Decramer, Marc, DiGiovanni, Robert, D’Andrea, Peter, Hu, Huilin, Goyal, Pankaj, Altman, Pablo
Udgivet 2015Text -
7
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study af Chapman, Kenneth R, Beeh, Kai-Michael, Beier, Jutta, Bateman, Eric D, D’Urzo, Anthony, Nutbrown, Robert, Henley, Michelle, Chen, Hungta, Overend, Tim, D’Andrea, Peter
Udgivet 2014Text -
8
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PAL... af Chapman, Kenneth, van Zyl-Smit, Richard, Maspero, Jorge, Kerstjens, Huib A M, Gon, Yasuhiro, Hosoe, Motoi, Tanase, Ana-Maria, Pethe, Abhijit, Shu, Xu, D’Andrea, Peter
Udgivet 2021Text -
9
IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid af Jan Naujoks, Christoph Tabeling, Brian D. Dill, Christine Hoffmann, A Brown, Mareike Kunze, Stefan Kempa, Andrea Péter, Hans‐Joachim Mollenkopf, Anca Dorhoi, Olivia Kershaw, Achim D. Gruber, Leif Erik Sander, Martin Witzenrath, Susanne Herold, Andreas Nerlich, Andreas C. Hocke, Ian R. van Driel, Norbert Suttorp, Sammy Bedoui, Hubert Hilbi, Matthias Trost, Bastian Opitz
Udgivet 2016Artigo